HCV Drug Resistance Challenges in Japan: The Role of Pre-Existing Variants and Emerging Resistant Strains in Direct Acting Antiviral Therapy

Sustained virological response (SVR) rates have increased dramatically following the approval of direct acting antiviral (DAA) therapies. While individual DAAs have a low barrier to resistance, most patients can be successfully treated using DAA combination therapy. However, DAAs are vulnerable to d...

Descripción completa

Detalles Bibliográficos
Autores principales: Chayama, Kazuaki, Hayes, C. Nelson
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632384/
https://www.ncbi.nlm.nih.gov/pubmed/26473914
http://dx.doi.org/10.3390/v7102876

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632384/
https://www.ncbi.nlm.nih.gov/pubmed/26473914
http://dx.doi.org/10.3390/v7102876

Ejemplares similares